Biblio Discovery — Demo Discovery Service

14 hasil

Menampilkan 1–14 · 0,51 detik · RSS

Jurnal

British Journal of Dermatology

Scopus

ISSN 0007-0963 · Oxford University Press · 14 artikel di indeks

  1. Artikel Jurnal Teks lengkap

    Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases

    Alba Català; Petunia Clavo-Escribano; Josep Riera‐Monroig dkk.

    British Journal of Dermatology · 2022 · Inggris · OpenAlex Scopus

    BACKGROUND: Since May 2022, a new outbreak of monkeypox has been reported in several countries, including Spain. The clinical and epidemiological characteristics of the cases in this outbreak may differ from those in earlier reports. OBJECTIVES: To document the clinical and epidemiological…

  2. Artikel Jurnal Teks lengkap

    Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

    Sophie Georgin‐Lavialle; Benjamin Terrier; Alexis F. Guédon dkk.

    British Journal of Dermatology · 2021 · Inggris · OpenAlex Scopus

    BACKGROUND: A new autoinflammatory syndrome related to somatic mutations of UBA1 was recently described and called VEXAS syndrome ('Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome'). OBJECTIVES: To describe clinical characteristics, laboratory findings and outcomes of VEXAS…

  3. Artikel Jurnal Teks lengkap

    Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases

    A. Català; Carlos Muñoz‐Santos; Cristina Galván‐Casas dkk.

    British Journal of Dermatology · 2021 · Inggris · OpenAlex Scopus

    BACKGROUND: Cutaneous reactions after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are poorly characterized. OBJECTIVE: To describe and classify cutaneous reactions after SARS-CoV-2 vaccination. METHODS: A nationwide Spanish cross-sectional study was conducted. We included…

  4. Artikel Jurnal Teks lengkap

    Role of regulatory T cells in psoriasis pathogenesis and treatment

    Lea Nußbaum; You‐Yue Chen; Graham Stuart Ogg

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    Psoriasis is a chronic inflammatory disease with a strong genetic component that can be triggered by environmental factors. Disease pathogenesis is mainly driven by type 1 and type 17 cytokine-producing cells which, in healthy individuals, are modulated by regulatory T cells (Tregs). Tregs play a…

  5. Artikel Jurnal Teks lengkap

    The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies

    Daniel Engelman; J. Yoshizumi; Roderick J. Hay dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Scabies is a common parasitic skin condition that causes considerable morbidity globally. Clinical and epidemiological research for scabies has been limited by a lack of standardization of diagnostic methods. OBJECTIVES: To develop consensus criteria for the diagnosis of common scabies…

  6. Artikel Jurnal Teks lengkap

    What is AI? Applications of artificial intelligence to dermatology

    Xinyi Du-Harpur; Fiona M. Watt; Nicholas M. Luscombe dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    In the past, the skills required to make an accurate dermatological diagnosis have required exposure to thousands of patients over many years. However, in recent years, artificial intelligence (AI) has made enormous advances, particularly in the area of image classification. This has led computer…

  7. Artikel Jurnal Teks lengkap

    SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases

    Isabel Colmenero; Carlos Santonja; Marina Alonso dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Chilblains ('COVID toes') are being seen with increasing frequency in children and young adults during the COVID-19 pandemic. Detailed histopathological descriptions of COVID-19 chilblains have not been reported, and causality of SARS-CoV-2 has not yet been established. OBJECTIVES: To…

  8. Artikel Jurnal Teks lengkap

    Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

    Jonathan I. Silverberg; D. Toth; Thomas R.M. Bieber dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin-13, a key driver of atopic dermatitis (AD). OBJECTIVES: To evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroids (TCS) in patients with moderate-to-severe…

  9. Artikel Jurnal Teks lengkap

    Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases

    Cristina Galván‐Casas; A. Català; G. Carretero Hernández dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: The cutaneous manifestations of COVID-19 disease are poorly characterized. OBJECTIVES: To describe the cutaneous manifestations of COVID-19 disease and to relate them to other clinical findings. METHODS: We carried out a nationwide case collection survey of images and clinical data…

  10. Artikel Jurnal Teks lengkap

    Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

    Cristina Has; Johann Wolfgang Bauer; Christine Bodemer dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Several new genes and clinical subtypes have been identified since the publication in 2014 of the report of the last International Consensus Meeting on Epidermolysis Bullosa (EB). OBJECTIVES: We sought to reclassify disorders with skin fragility, with a focus on EB, based on new…

  11. Artikel Jurnal Teks lengkap

    The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*

    Melissa Ronni Laughter; Mayra B.C. Maymone; Soudeh Mashayekhi dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: The Global Burden of Disease (GBD) Study provides an annually updated resource to study disease-related morbidity and mortality worldwide. OBJECTIVES: Here we present the burden estimates for atopic dermatitis (AD), including data from inception of the GBD project in 1990 until 2017…

  12. Artikel Jurnal Teks lengkap

    Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    Andreas Wollenberg; Andrew Blauvelt; Emma Guttman‐Yassky dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Tralokinumab, a fully human monoclonal antibody, specifically neutralizes interleukin-13, a key cytokine driving peripheral inflammation in atopic dermatitis (AD). In phase II studies, tralokinumab combined with topical corticosteroids provided early and sustained improvements in AD…

  13. Artikel Jurnal Teks lengkap

    British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update

    Catherine Smith; Zenas Z N Yiu; Tracy Bale dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    Linked Comment:Ormerod. Br J Dermatol 2020; 183:604. Plain language summary available online

  14. Artikel Jurnal Teks lengkap

    Cutaneous manifestations in patients with COVID‐19: a preliminary review of an emerging issue

    Angelo Valerio Marzano; Nicoletta Cassano; Giovanni Genovese dkk.

    British Journal of Dermatology · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: The infection caused by the recently identified SARS-CoV-2, called coronavirus disease-19 (COVID-19), has rapidly spread throughout the world. With the exponential increase of patients worldwide, the clinical spectrum of COVID-19 is being better defined and new symptoms are emerging…